Georg Ebersbach
Research Subjects
Georg Ebersbach has a total of 542 co-authors. Here are the top co-authors by number of shared publications:
- Florin Gandor
Movement Disorders Hospital, Beelitz-Heilstätten, Germany
20 shared publications Werner Poewe
Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria
14 shared publicationsPer Odin
Division of Neurology, Department of Clinical Sciences, Lund University, 22185, Lund, Sweden
11 shared publicationsW. Poewe
Universitätsklinik für Neurologie, Medizinische Universität Innsbruck, Innsbruck, Österreich
10 shared publicationsHeinz Reichmann
9 shared publications- Kallol Ray Chaudhuri
King’s College Hospital
9 shared publications
Latest Publications
- 27 August 2026
- Published by Springer Nature in Journal of Neural Transmission
- Vol. 133 (10) , 3033-3041
Not always the usual suspect: symptom variations in Parkinson’s disease beyond ON-OFF fluctuations
In addition to response fluctuations caused by the pharmacokinetics of dopamine replacement medication, temporal variation in the expression and severity of motor and non-motor symptoms, which is not or only partially attributable to the effects of the medication, are also common in Parkinson’s disease (PD). The spectrum of transient changes of motor symptom expression unrelated to the classical ON-OFF fluctuations ranges from brief episodes of gait freezing or tremor breakthroughs to severe akinetic crisis and non-motor phenomena include discontinuous changes in cognition and vigilance. Disease-related factors such as dementia or orthostatic dysregulation or disturbances of the circadian rhythm may also contribute to these non-pharmacological symptom fluctuations. Additionally, external factors including infections or surgery and general anaesthesia can lead to transient changes of PD symptom severity and drug responsiveness. Accurately classifying these symptom oscillations and distinguishing them from drug-induced ON-OFF fluctuations is essential for their appropriate management.
- 27 August 2026
- Published by Springer Nature in Journal of Neural Transmission
- Vol. 133 (10) , 3033-3041
Not always the usual suspect: symptom variations in Parkinson’s disease beyond ON-OFF fluctuations
In addition to response fluctuations caused by the pharmacokinetics of dopamine replacement medication, temporal variation in the expression and severity of motor and non-motor symptoms, which is not or only partially attributable to the effects of the medication, are also common in Parkinson’s disease (PD). The spectrum of transient changes of motor symptom expression unrelated to the classical ON-OFF fluctuations ranges from brief episodes of gait freezing or tremor breakthroughs to severe akinetic crisis and non-motor phenomena include discontinuous changes in cognition and vigilance. Disease-related factors such as dementia or orthostatic dysregulation or disturbances of the circadian rhythm may also contribute to these non-pharmacological symptom fluctuations. Additionally, external factors including infections or surgery and general anaesthesia can lead to transient changes of PD symptom severity and drug responsiveness. Accurately classifying these symptom oscillations and distinguishing them from drug-induced ON-OFF fluctuations is essential for their appropriate management.
- Open Access
- 30 January 2026
- Published by Wiley in Movement Disorders Clinical Practice
- Vol. 13 (7) , 1637-1641
Refractory Motor Complications: Towards a Pragmatic Definition
- 30 January 2026
- Published by Wiley in Movement Disorders Clinical Practice
- Vol. 13 (7) , 1637-1641
Open AccessRefractory Motor Complications: Towards a Pragmatic Definition
- 19 November 2025
- Published by Wiley in Movement Disorders Clinical Practice
- Vol. 13 (4) , 1111-1112
REPLY : Foslevodopa/Foscarbidopa Continuous Subcutaneous Infusion in Parkinson's Disease: Extended Real World Data With Outpatient Dose Titration
- 19 November 2025
- Published by Wiley in Movement Disorders Clinical Practice
- Vol. 13 (4) , 1111-1112
REPLY : Foslevodopa/Foscarbidopa Continuous Subcutaneous Infusion in Parkinson's Disease: Extended Real World Data With Outpatient Dose Titration
- Open Access
- 12 September 2025
- Published by Wiley in Movement Disorders Clinical Practice
- Vol. 13 (3) , 683-691
Is Dysphagia in Multiple System Atrophy Responsive to Levodopa? Results from a Retrospective Study
Background: Dysphagia remains a major clinical concern in multiple system atrophy (MSA), and so far, lacks relevant treatment options. Objective: To systematically assess levodopa‐responsiveness of dysphagia in MSA. Methods: 19 MSA‐patients underwent endoscopic swallowing evaluation in Off‐ and On‐state, following an adapted FEES‐levodopa‐test‐protocol. Findings were compared between states and correlated to disease‐specific and demographic factors. Results: All 19 MSA‐patients 70 [66–72] years, 15/4 MSA‐P/ C, 10 women exhibited dysphagia. Levodopa‐responsiveness of motor‐impairment was poor (UPDRS‐3 Off 46 [34–52] vs On 43 [40–48], P = 0.31). Dysphagia severity varied greatly. Sum‐scores ranged between 9–21 in Off and 6–20 in On. MSA‐P‐patients were more likely to have higher sum‐scores (rpb 0.41, P = 0.01). Sum‐scores otherwise were independent of disease‐specific and demographic factors. 3/19 MSA‐patients showed marked score‐improvement by ≥30% through reduced leaking and aspiration but remained unchanged for the majority. Scores worsened in 2/19 patients. In the group analysis, the median dysphagia‐score remained unchanged (2 [1, 2], P = 0.28). The occurrence of leaking, pharyngeal residue, penetration, and aspiration was not changed ( P = 0.13–0.19). Severity of leaking was reduced (3 [2–4] vs. 0[0.5–1], P < 0.0001), while severity of pharyngeal residue, penetration, and aspiration remained unchanged ( P = 0.29–0.53). Liquids were more often associated with leaking ( P < 0.05) and aspiration ( P < 0.005). All patients exhibited laryngeal movement disorders, with irregular arytenoid cartilage movements (iACM) being observed in all patients, regardless of levodopa‐state. Conclusion: The levodopa‐response in MSA‐related dysphagia varies greatly. Some patients might improve markedly, necessitating individual assessments to tailor patient‐specific therapies. Non‐pharmacological measures should be investigated to address dysphagia in MSA. IACM again proved to be highly prevalent in MSA.
- 12 September 2025
- Published by Wiley in Movement Disorders Clinical Practice
- Vol. 13 (3) , 683-691
Open AccessIs Dysphagia in Multiple System Atrophy Responsive to Levodopa? Results from a Retrospective Study
Background: Dysphagia remains a major clinical concern in multiple system atrophy (MSA), and so far, lacks relevant treatment options. Objective: To systematically assess levodopa‐responsiveness of dysphagia in MSA. Methods: 19 MSA‐patients underwent endoscopic swallowing evaluation in Off‐ and On‐state, following an adapted FEES‐levodopa‐test‐protocol. Findings were compared between states and correlated to disease‐specific and demographic factors. Results: All 19 MSA‐patients 70 [66–72] years, 15/4 MSA‐P/ C, 10 women exhibited dysphagia. Levodopa‐responsiveness of motor‐impairment was poor (UPDRS‐3 Off 46 [34–52] vs On 43 [40–48], P = 0.31). Dysphagia severity varied greatly. Sum‐scores ranged between 9–21 in Off and 6–20 in On. MSA‐P‐patients were more likely to have higher sum‐scores (rpb 0.41, P = 0.01). Sum‐scores otherwise were independent of disease‐specific and demographic factors. 3/19 MSA‐patients showed marked score‐improvement by ≥30% through reduced leaking and aspiration but remained unchanged for the majority. Scores worsened in 2/19 patients. In the group analysis, the median dysphagia‐score remained unchanged (2 [1, 2], P = 0.28). The occurrence of leaking, pharyngeal residue, penetration, and aspiration was not changed ( P = 0.13–0.19). Severity of leaking was reduced (3 [2–4] vs. 0[0.5–1], P < 0.0001), while severity of pharyngeal residue, penetration, and aspiration remained unchanged ( P = 0.29–0.53). Liquids were more often associated with leaking ( P < 0.05) and aspiration ( P < 0.005). All patients exhibited laryngeal movement disorders, with irregular arytenoid cartilage movements (iACM) being observed in all patients, regardless of levodopa‐state. Conclusion: The levodopa‐response in MSA‐related dysphagia varies greatly. Some patients might improve markedly, necessitating individual assessments to tailor patient‐specific therapies. Non‐pharmacological measures should be investigated to address dysphagia in MSA. IACM again proved to be highly prevalent in MSA.
- 29 July 2025
- Published by Georg Thieme Verlag KG in Geriatrie up2date
- Vol. 07 (03) , 201-215
Subtypen der Parkinson-Krankheit
Parkinson ist ein Krankheitsbild mit von Mensch zu Mensch sehr unterschiedlichen Symptomkonstellationen und Verlaufsformen. Im klinischen Alltag werden oft für die Gesamtgruppe der Betroffenen definierte Therapiestrategien eingesetzt, die dann allerdings zu sehr variablen Ergebnissen führen. Die Definition von verschiedenen Parkinson-Subtypen soll dazu dienen, den individuellen Krankheitsverlauf besser einschätzen zu können und die für verschiedene Untergruppen am besten geeigneten Behandlungsmöglichkeiten zu finden. Article published online: 29 July 2025 © 2025. Thieme. All rights reserved. Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
- 29 July 2025
- Published by Georg Thieme Verlag KG in Geriatrie up2date
- Vol. 07 (03) , 201-215
Subtypen der Parkinson-Krankheit
Parkinson ist ein Krankheitsbild mit von Mensch zu Mensch sehr unterschiedlichen Symptomkonstellationen und Verlaufsformen. Im klinischen Alltag werden oft für die Gesamtgruppe der Betroffenen definierte Therapiestrategien eingesetzt, die dann allerdings zu sehr variablen Ergebnissen führen. Die Definition von verschiedenen Parkinson-Subtypen soll dazu dienen, den individuellen Krankheitsverlauf besser einschätzen zu können und die für verschiedene Untergruppen am besten geeigneten Behandlungsmöglichkeiten zu finden. Article published online: 29 July 2025 © 2025. Thieme. All rights reserved. Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
- 10 June 2025
- Published by Georg Thieme Verlag KG in Fortschritte der Neurologie · Psychiatrie
- Vol. 93 (06) , 243-254
Subtypen der Parkinson-Krankheit
Parkinson ist ein Krankheitsbild mit von Mensch zu Mensch sehr unterschiedlichen Symptomkonstellationen und Verlaufsformen. Im klinischen Alltag werden oft für die Gesamtgruppe der Betroffenen definierte Therapiestrategien eingesetzt, die dann allerdings zu sehr variablen Ergebnissen führen. Die Definition von verschiedenen Parkinson-Subtypen soll dazu dienen, den individuellen Krankheitsverlauf besser einschätzen zu können und die für verschiedene Untergruppen am besten geeigneten Behandlungsmöglichkeiten zu finden. Parkinsonʼs disease is characterized by a large inter-individual variability of symptom constellations and courses. In routine clinical practice, standard treatment strategies are often used, but outcomes differ considerably from patient to patient. The definition of different Parkinson's subtypes may help to better predict the individual course of the disease and to find the most suitable treatment options for different patient groups. Article published online: 10 June 2025 © 2025. Thieme. All rights reserved. Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
- 10 June 2025
- Published by Georg Thieme Verlag KG in Fortschritte der Neurologie · Psychiatrie
- Vol. 93 (06) , 243-254
Subtypen der Parkinson-Krankheit
Parkinson ist ein Krankheitsbild mit von Mensch zu Mensch sehr unterschiedlichen Symptomkonstellationen und Verlaufsformen. Im klinischen Alltag werden oft für die Gesamtgruppe der Betroffenen definierte Therapiestrategien eingesetzt, die dann allerdings zu sehr variablen Ergebnissen führen. Die Definition von verschiedenen Parkinson-Subtypen soll dazu dienen, den individuellen Krankheitsverlauf besser einschätzen zu können und die für verschiedene Untergruppen am besten geeigneten Behandlungsmöglichkeiten zu finden. Parkinsonʼs disease is characterized by a large inter-individual variability of symptom constellations and courses. In routine clinical practice, standard treatment strategies are often used, but outcomes differ considerably from patient to patient. The definition of different Parkinson's subtypes may help to better predict the individual course of the disease and to find the most suitable treatment options for different patient groups. Article published online: 10 June 2025 © 2025. Thieme. All rights reserved. Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
- 27 February 2025
- Published by Springer Nature in DGNeurologie
- Vol. 8 (2) , 156-159
Viele Wege führen zum Ziel: Was bewirkt Bewegungstraining bei Parkinson?
- 27 February 2025
- Published by Springer Nature in DGNeurologie
- Vol. 8 (2) , 156-159
Viele Wege führen zum Ziel: Was bewirkt Bewegungstraining bei Parkinson?
- 8 October 2024
- Published by Springer Nature in DGNeurologie
- Vol. 7 (6) , 453-460
Zustandsschwankungen bei der Parkinson-Krankheit jenseits von On‑/Off-Fluktuationen
- 8 October 2024
- Published by Springer Nature in DGNeurologie
- Vol. 7 (6) , 453-460
Zustandsschwankungen bei der Parkinson-Krankheit jenseits von On‑/Off-Fluktuationen
- 9 September 2024
- Published by Georg Thieme Verlag KG in Neurologie up2date
- Vol. 07 (03) , 209-223
Subtypen der Parkinson-Krankheit
Parkinson ist ein Krankheitsbild mit von Mensch zu Mensch sehr unterschiedlichen Symptomkonstellationen und Verlaufsformen. Im klinischen Alltag werden oft für die Gesamtgruppe der Betroffenen definierte Therapiestrategien eingesetzt, die dann allerdings zu sehr variablen Ergebnissen führen. Die Definition von verschiedenen Parkinson-Subtypen soll dazu dienen, den individuellen Krankheitsverlauf besser einschätzen zu können und die für verschiedene Untergruppen am besten geeigneten Behandlungsmöglichkeiten zu finden. Article published online: 09 September 2024 © 2024. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
- 9 September 2024
- Published by Georg Thieme Verlag KG in Neurologie up2date
- Vol. 07 (03) , 209-223
Subtypen der Parkinson-Krankheit
Parkinson ist ein Krankheitsbild mit von Mensch zu Mensch sehr unterschiedlichen Symptomkonstellationen und Verlaufsformen. Im klinischen Alltag werden oft für die Gesamtgruppe der Betroffenen definierte Therapiestrategien eingesetzt, die dann allerdings zu sehr variablen Ergebnissen führen. Die Definition von verschiedenen Parkinson-Subtypen soll dazu dienen, den individuellen Krankheitsverlauf besser einschätzen zu können und die für verschiedene Untergruppen am besten geeigneten Behandlungsmöglichkeiten zu finden. Article published online: 09 September 2024 © 2024. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany